论文部分内容阅读
摘要目的通过对贝伐珠单抗治疗复发性脑胶质瘤(GBM)病人的随机多中心临床研究,对照对比剂增强(CE)T1加权减影地形图与常规节段法协助预期诊断临床结果,包括
Abstract Objective To evaluate the clinical outcomes of bevacizumab in the treatment of patients with recurrent glioma (GBM) by randomized multicenter clinical trial. Contrast-enhanced (CE) T1 weighted subtraction topography and conventional segmental method ,include